← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Germano Geno J
Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001424383
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 4
- Purchases · 24M
- 6
- Average purchase
- $20.0K
- Median purchase
- $16.8K
- Gross purchase value
- $119.8K
Companies: Entera Bio Ltd. | PRECISION BIOSCIENCES INC
6 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-09-29 | PRECISION BIOSCIENCES INC | DTIL | Director | $16.4K | Open filing |
| 2026-03-11 | Entera Bio Ltd. | ENTX | Director | $26.0K | Open filing |
| 2026-02-11 | Entera Bio Ltd. | ENTX | Director | $29.8K | Open filing |
| 2025-12-17 | PRECISION BIOSCIENCES INC | DTIL | Director | $14.2K | Open filing |
| 2025-03-27 | PRECISION BIOSCIENCES INC | DTIL | Director | $17.2K | Open filing |
| 2025-01-02 | PRECISION BIOSCIENCES INC | DTIL | Director | $16.2K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 1/5
- Large purchase ≥ $100k
- 0/6
- Cluster buying · 15D
- 5/6
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.